The opioid crisis remains a significant public health challenge in the United States. In 2022, over 2.5 million American ...
The medical supplies industry has experienced significant growth in recent years. Several factors, including an aging ...
GLP-1 receptor agonists were originally developed for the treatment of type 2 diabetes, and later of obesity, but there is growing evidence that their benefits extend far beyond reductions in blood ...